| Dr Heather Mitzel Levy, DO | |
|
University Of Kansas Medical Ctr, 3901 Rainbow Boulevard, Kansas City, KS 66160-0001 | |
| (913) 588-6670 | |
| Not Available |
| Full Name | Dr Heather Mitzel Levy |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 19 Years |
| Location | University Of Kansas Medical Ctr, Kansas City, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952615577 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 0535939 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Kansas Hospital | Kansas city, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kansas University Physicians, Inc. | 8921911587 | 1456 |
News Archive
The Population Council announced today the launch of a large new research program designed to benefit adolescent girls in Kenya. The initiative will provide girls with access to interventions in the health, wealth creation, education, and violence-prevention sectors.
Cook Medical has initiated a clinical study in the U.S. to evaluate the removability of a new Evolution Esophageal Fully Covered Stent. This is the first multicenter U.S. study to evaluate the possibility of removing a self-expanding metal stent after malignant and benign strictures have been treated. The stent design used in the study has been modified to accommodate retrieval.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Notices of Allowance were recently issued by the United States Patent Office (USPTO) on patent applications filed by Thermo Fisher Scientific Inc. and licensed to RXi Pharmaceuticals encompassing small interfering RNA (siRNA) sequences targeting superoxide dismutase (SOD1), Amyloid beta (A4) precursor protein (APP), interleukin-1 receptor-associated kinase 4 (IRAK4), hepatocyte growth factor receptor (MET protooncogene) and cyclin-dependent kinase (cdk) inhibitor p27 (also known as Kip1, CDKN1B).
A shocking new report from a nonprofit organization called The White Coat Waste Project published this week found that the U.S. Department of Agriculture (USDA) has been conducting some abhorrent and bizarre experiments with cats and dogs.
› Verified 7 days ago
| Entity Name | Kansas University Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003858333 PECOS PAC ID: 8921911587 Enrollment ID: O20040401000328 |
News Archive
The Population Council announced today the launch of a large new research program designed to benefit adolescent girls in Kenya. The initiative will provide girls with access to interventions in the health, wealth creation, education, and violence-prevention sectors.
Cook Medical has initiated a clinical study in the U.S. to evaluate the removability of a new Evolution Esophageal Fully Covered Stent. This is the first multicenter U.S. study to evaluate the possibility of removing a self-expanding metal stent after malignant and benign strictures have been treated. The stent design used in the study has been modified to accommodate retrieval.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Notices of Allowance were recently issued by the United States Patent Office (USPTO) on patent applications filed by Thermo Fisher Scientific Inc. and licensed to RXi Pharmaceuticals encompassing small interfering RNA (siRNA) sequences targeting superoxide dismutase (SOD1), Amyloid beta (A4) precursor protein (APP), interleukin-1 receptor-associated kinase 4 (IRAK4), hepatocyte growth factor receptor (MET protooncogene) and cyclin-dependent kinase (cdk) inhibitor p27 (also known as Kip1, CDKN1B).
A shocking new report from a nonprofit organization called The White Coat Waste Project published this week found that the U.S. Department of Agriculture (USDA) has been conducting some abhorrent and bizarre experiments with cats and dogs.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Heather Mitzel Levy, DO University Of Kansas Medical Ctr, 3901 Rainbow Boulevard, Kansas City, KS 66160-0001 Ph: (913) 588-6670 | Dr Heather Mitzel Levy, DO University Of Kansas Medical Ctr, 3901 Rainbow Boulevard, Kansas City, KS 66160-0001 Ph: (913) 588-6670 |
News Archive
The Population Council announced today the launch of a large new research program designed to benefit adolescent girls in Kenya. The initiative will provide girls with access to interventions in the health, wealth creation, education, and violence-prevention sectors.
Cook Medical has initiated a clinical study in the U.S. to evaluate the removability of a new Evolution Esophageal Fully Covered Stent. This is the first multicenter U.S. study to evaluate the possibility of removing a self-expanding metal stent after malignant and benign strictures have been treated. The stent design used in the study has been modified to accommodate retrieval.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Notices of Allowance were recently issued by the United States Patent Office (USPTO) on patent applications filed by Thermo Fisher Scientific Inc. and licensed to RXi Pharmaceuticals encompassing small interfering RNA (siRNA) sequences targeting superoxide dismutase (SOD1), Amyloid beta (A4) precursor protein (APP), interleukin-1 receptor-associated kinase 4 (IRAK4), hepatocyte growth factor receptor (MET protooncogene) and cyclin-dependent kinase (cdk) inhibitor p27 (also known as Kip1, CDKN1B).
A shocking new report from a nonprofit organization called The White Coat Waste Project published this week found that the U.S. Department of Agriculture (USDA) has been conducting some abhorrent and bizarre experiments with cats and dogs.
› Verified 7 days ago
Lyna Rehan, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd # Ms 1034, Kansas City, KS 66160 Phone: 913-588-3304 Fax: 913-588-3365 | |
Dr. Joel Kent Grigsby, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-3315 | |
O. Layton Alldredge Jr., MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: Kansas University Medical Ctr, 3901 Rainbow Blvd Ms 1034, Kansas City, KS 66160 Phone: 913-588-3304 | |
Timothy Sowder, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: Kumc 3901 Rainbow Blvd Ms 1034, Kansas City, KS 66160 Phone: 913-588-3302 Fax: 913-588-3365 | |
Robert P Devine, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-3315 | |
Jennifer B Kenny, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Mail Stop 1034, Kansas City, KS 66160 Phone: 913-588-3315 Fax: 913-588-3365 | |
Dr. Sarafina Kristine Kankam, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-5000 |